Nuo Therapeutics, Inc. (AURX) Total liabilities 2017–2025
Nuo Therapeutics, Inc. (AURX) total liabilities at each fiscal year-end, per SEC filings.
$2.8MFY2025 · since FY2017: $941,168 → $2.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.8M | +314.7% |
| FY2024 | $675,796 | -19.4% |
| FY2023 | $838,732 | -2.0% |
| FY2022 | $856,022 | +27.2% |
| FY2021 | $673,079 | +1.2% |
| FY2020 | $664,951 | -55.2% |
| FY2019 | $1.5M | +40.5% |
| FY2018 | $1.1M | +12.4% |
| FY2017 | $941,168 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More AURX financial trends
AURX RevenueAURX Net incomeAURX Net marginAURX Gross profitAURX Gross marginAURX Operating incomeAURX Operating marginAURX Operating cash flowAURX Free cash flowAURX Capital expendituresAURX Return on equityAURX Stock buybacksAURX Dividends paidAURX Total assetsAURX Shareholders’ equityAURX overview →